A Study to Compare DB-1303/BNT323 Versus T-DM1 in Breast Cancer

Clinical trial NCT06265428 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06265428
Sponsor: DualityBio Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

HER2-positive Breast Cancer

Start date: 2024-01-29
Primary completion: 2026-02-01
Enrollment: 228

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.